ACR Open Rheumatology (Jun 2023)
Use of Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision‐Making Between Patients With Cancer and Clinicians
Abstract
No abstracts available.
ACR Open Rheumatology (Jun 2023)